Xiaoling Li, Ph.D. is a Professor of Pharmaceutics and Associate Dean of Graduate Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific. Dr. Li is a Fellow of American Association of Pharmaceutical Scientists. He received BS in Pharmacy and MS in Nuclear Pharmacy from Shanghai Medical University in 1982 and 1985, respectively. Under the guidance of Dr. Sung Wan Kim, Dr. Li obtained his Ph.D. in Pharmaceutics from the University of Utah in 1991. Prior to his academic career, he was a postdoctoral research fellow at Ciba-Geigy Corp (now Novartis). Dr. Li’s research interest areas include oral mucosal drug delivery, novel polymers for pharmaceutical and medical application, targeting drug delivery, drug transport through biological membranes, and application of physicochemical concepts to novel dosage form design. His research projects are funded by both NIH and pharmaceutical industry. He holds 3 patents with 3 patent applications pending and has published more than 80 papers/book chapters, over 130 abstracts/presentations, including books entitled “Design of Controlled Release Drug Delivery Systems” and “Oral Bioavailability”. Dr. Li received CRS Outstanding Paper Award for the Journal of Controlled Release in 1992. He is a Thomas J. Long Fellow and recognized as a Distinguished Faculty Research Lecturer (2003) and received Distinguished Faculty Award (2012) at the University of the Pacific. Dr. Li is a member of the Association of American Pharmaceutical Scientists, Controlled Release Society, and a convention member of USP. Dr. Li has mentored and trained 21 Ph.D., 10 post doctoral research fellows, and 12 visiting scientists. He co-founded Formurex, Inc., a formulation development company in 2006. Dr. Li works closely with the pharmaceutical industry and provides consultation for product development to various pharmaceutical companies.